Monkey combs through the losers at the back of his King of the Jungle portfolio and asks whether you should add on big drops. He never added to $MRLN, now down close to 80%, and says that was right; but holding back on Chainlink cost him a double. Badger reviews Thomas Chua's The Lunch Break Investor, and reflects on his own $NIKE misstep. After Monkey's $NKTR update on the Lilly verdict, Badger stress-tests his own high-conviction $AMZN position against the capex bill and the rise of shopping agents.
🐒 Monkey bought $MRLN at about $8, already 50% off the top, and never added as it kept falling
🔗 Chainlink gave him a technical buy signal in early September; he passed and $LINK doubled
🧬 $NKTR won $90m from Lilly at trial, a tenth of the $1bn some investors had hoped for. Monkey says about $1bn in cash lasts to mid-2028, and he puts the buyout odds above 50%
🎋 The Lunch Break Investor says wealth compounds like bamboo (a simile, Monkey points out)
👟 Luke owns his $NIKE call: the direct-to-consumer pivot handed shelf space to rival brands
📦 On $AMZN, ads topped $76bn over the last 12 months and AWS brought in $148bn at a 39% margin
🤖 Luke's worry: shopping agents like $META's Muse won't be lured by Amazon's ads
SOURCES
The Lunch Break Investor: https://steadycompounding.com/the-lunch-break-investor/
Best Stock Market Podcasts For Beginners (we're number nine!): https://podcast.feedspot.com/stock_market_podcasts_for_beginners/
SEGMENTS
00:00 Cold open
00:32 Intro: big drops and Nektar from Monkey, Amazon from Badger
01:06 WSOP Malta: the poker Badger never played
04:12 Big drops: why Monkey didn't average down
06:11 $MRLN: correct not to add
09:43 Chainlink: a mistake not to add
15:00 Live stablecoin question and the November 10x revisit
20:12 $PRCT and $OPEN: same rule, the first bite is enough
21:20 The Lunch Break Investor: compounding like bamboo
27:00 Brand as a verb, and Badger's Nike confession
33:19 Spawners vs diworsifiers: AWS and the Fire Phone
37:26 Should you buy $NKTR? The update after the Lilly verdict
43:49 $NKTR Q&A: adding, and biotech buyout premiums
48:20 Should you buy $AMZN? Two businesses under one roof
52:11 Capex eats free cash flow again, and the Anthropic bet
56:01 Agentic commerce: Meta's Muse and Amazon's ad business
01:00:29 Monkey shares the capex worry; why Google's first-party data is different
01:07:25 Left field: Meta, $ASTS, Starship and Monkey's big call
01:12:07 Fiscal.ai thanks and sign-off
**********
If you want to see our furry faces, this podcast is also available on YouTube at youtube.com/@WallStreetWildlife?sub_confirmation=1
**********
SUPPORT THE SHOW AND BECOME A PATREON:
wallstreetwildlife.com
**********
Follow us at:
x.com/7LukeHallard
x.com/7FlyingPlatypus
**********
Fiscal.AI is the Complete Stock Research Platform for fundamental investors. With its beautiful design and institutional-quality data, Fiscal AI is incredibly powerful and easy to use.
Get 15% off any premium plan with:
fiscal.ai/wildlife
**********
Monkey’s “Zen, Nietzsche, How to Live” Substack:
firephilosophy.substack.com
**********
To use the same portfolio tracking tool as Luke, check-out:
portseido.com/?fpr=lukehallard
**********
Disclosure: Wall Street Wildlife hosts and guests are not financial advisors, and nothing they say on this show is formal advice or a recommendation
**********
Fed up with the stock market giving you a hard time?
- Invest like seasoned pros with over 40 years in the game
- Discover the world's leading companies
- Sharpen your best investing practices and ditch the worst
- Learn how to start investing
- Essential investing principles to boost your returns
